This patient survived a dozen tumors. Here’s what we can learn from their unique immune system

Credit: Op-Med
Credit: Op-Med

A unique patient who has survived the development of a dozen tumors could hold the key to curing cancer, a new study reveals.

Their review found that the individual is “programmed” to develop different forms of the disease after inheriting mutations in a gene from both parents. However, their immune system naturally generates a strong anti-inflammatory response that fights the growths. Knowing how it does this offers a “groundbreaking” hope of earlier disease diagnosis and new immunotherapy drugs.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The unnamed patient around the age of 40 has had 12 tumors, with at least five of them being malignant. The first developed during infancy, followed by others every few years. Each has been of a different type and in a different part of the body. The patient also has skin spots, the birth defect microcephaly which causes a smaller head and brain, and other alterations.

According to Malumbres, the study of this unique case opens up “a way to detect cells with tumor potential well in advance of clinical tests and diagnostic imaging. It also provides a novel way to stimulate the immune response to a cancerous process.”

This is an excerpt. Read the full article here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screen Shot at AM
Facts & Fallacies Podcast: Right-wing politics bad for your health? Separating speculation from science
ChatGPT-Image-Jun-9-2026-01_11_37-PM
Turmeric supplements: More risks than benefits
ChatGPT-Image-Jun-15-2026-11_00_13-AM-2
Glucosamine alert: Alzheimer’s progresses faster among those taking the popular supplement
ChatGPT-Image-Jun-15-2026-12_13_41-PM
Viewpoint: Behind the effort to re-purpose the tobacco attack strategy to fight ultra-processed foods
ChatGPT-Image-Jun-3-2026-04_29_13-PM
Viewpoint: While unvaccinated children are dying overseas, Congress challenges Trump and Kennedy’s block on aid
Screenshot-2026-06-12-at-2.10.55-PM
Physician warns online statin myths delay care and raise heart risk
Screenshot-2026-06-14-at-9.14.26-AM
‘Humanitarian catastrophe’: Trump’s USAID shutdown could help drive nearly 23 million deaths — including 5.4 million children — by 2030, Lancet study warns
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
ChatGPT-Image-Jun-14-2026-09_41_44-AM-2
Viewpoint—‘The gleeful efficiency of an arsonist’: Administration’s health and science research cuts are ‘sabotaging’ America’s future
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-16-at-12.33.01-PM
Who’s responsible when AI lies? Google challenging court ruling that search results are not protected from legal liability
ChatGPT-Image-Jun-15-2026-10_42_06-AM
Viewpoint: ‘Steroid Olympics’ marketing stunt: ‘It seemed less like a sporting event and more like a loss leader to peddle testosterone injections, GLP-1s, and peptides’
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.